IL121036A0 - Method of enhancing cognition - Google Patents
Method of enhancing cognitionInfo
- Publication number
- IL121036A0 IL121036A0 IL12103697A IL12103697A IL121036A0 IL 121036 A0 IL121036 A0 IL 121036A0 IL 12103697 A IL12103697 A IL 12103697A IL 12103697 A IL12103697 A IL 12103697A IL 121036 A0 IL121036 A0 IL 121036A0
- Authority
- IL
- Israel
- Prior art keywords
- enhancing cognition
- darifenacin
- treatment
- pharmaceutically acceptable
- cognitive impairment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/01—Carboxylic ester hydrolases (3.1.1)
- C12Y301/01007—Acetylcholinesterase (3.1.1.7)
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Control Of Eletrric Generators (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Soil Working Implements (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Chemical Treatment Of Metals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9612710.5A GB9612710D0 (en) | 1996-06-18 | 1996-06-18 | Method of treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
IL121036A0 true IL121036A0 (en) | 1997-11-20 |
Family
ID=10795468
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL12103697A IL121036A0 (en) | 1996-06-18 | 1997-06-09 | Method of enhancing cognition |
Country Status (15)
Country | Link |
---|---|
US (1) | US5837724A (pt) |
EP (1) | EP0813870B1 (pt) |
JP (1) | JP3453493B2 (pt) |
KR (1) | KR980000445A (pt) |
AT (1) | ATE243514T1 (pt) |
AU (1) | AU2495697A (pt) |
CA (1) | CA2208111C (pt) |
DE (1) | DE69722999T2 (pt) |
DK (1) | DK0813870T3 (pt) |
ES (1) | ES2197972T3 (pt) |
GB (1) | GB9612710D0 (pt) |
HU (1) | HUP9701060A3 (pt) |
IL (1) | IL121036A0 (pt) |
PT (1) | PT813870E (pt) |
ZA (1) | ZA975311B (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19707655A1 (de) * | 1997-02-26 | 1998-08-27 | Hoechst Ag | Kombinationspräparat zur Anwendung bei Demenz |
US20040209849A1 (en) * | 1998-11-27 | 2004-10-21 | Sanochemia Pharmazeutika Aktiengesellschaft | Use of effectors of the central cholinergic nervous system for treatment of delirium |
GB0207104D0 (en) * | 2002-03-26 | 2002-05-08 | Pfizer Ltd | Stable hydrate of a muscarinic receptor antagonist |
US7317102B2 (en) * | 2003-04-01 | 2008-01-08 | Theravance, Inc. | Diarylmethyl and related compounds |
AU2009229372C1 (en) | 2008-03-27 | 2017-02-02 | Chase Pharmaceuticals Corporation | Use and composition for treating dementia |
EP3646870A1 (en) * | 2009-07-22 | 2020-05-06 | Puretech Health LLC | Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation |
US10265311B2 (en) | 2009-07-22 | 2019-04-23 | PureTech Health LLC | Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation |
SG10202113198TA (en) * | 2017-06-01 | 2021-12-30 | Eisai R&D Man Co Ltd | Dementia therapeutic agent combining pyrazoloquinoline derivative and donepezil |
KR102408292B1 (ko) | 2018-09-28 | 2022-06-10 | 카루나 세러퓨틱스 인코포레이티드 | 무스카린성 수용체 활성화에 의해 개선된 장애의 치료를 위한 조성물 및 방법 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5233053A (en) * | 1989-03-17 | 1993-08-03 | Pfizer Inc. | Pyrrolidine derivatives |
GB9400600D0 (en) * | 1994-01-14 | 1994-03-09 | Pfizer Ltd | Treatment of motion seckness |
-
1996
- 1996-06-18 GB GBGB9612710.5A patent/GB9612710D0/en active Pending
-
1997
- 1997-06-05 DK DK97303879T patent/DK0813870T3/da active
- 1997-06-05 DE DE69722999T patent/DE69722999T2/de not_active Expired - Lifetime
- 1997-06-05 AT AT97303879T patent/ATE243514T1/de active
- 1997-06-05 ES ES97303879T patent/ES2197972T3/es not_active Expired - Lifetime
- 1997-06-05 PT PT97303879T patent/PT813870E/pt unknown
- 1997-06-05 EP EP97303879A patent/EP0813870B1/en not_active Expired - Lifetime
- 1997-06-09 IL IL12103697A patent/IL121036A0/xx unknown
- 1997-06-10 JP JP15189997A patent/JP3453493B2/ja not_active Expired - Lifetime
- 1997-06-11 US US08/872,891 patent/US5837724A/en not_active Expired - Lifetime
- 1997-06-16 CA CA002208111A patent/CA2208111C/en not_active Expired - Lifetime
- 1997-06-17 ZA ZA975311A patent/ZA975311B/xx unknown
- 1997-06-17 HU HU9701060A patent/HUP9701060A3/hu unknown
- 1997-06-17 AU AU24956/97A patent/AU2495697A/en not_active Abandoned
- 1997-06-17 KR KR1019970025073A patent/KR980000445A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ZA975311B (en) | 1998-12-17 |
ES2197972T3 (es) | 2004-01-16 |
JP3453493B2 (ja) | 2003-10-06 |
DE69722999T2 (de) | 2003-12-18 |
HUP9701060A3 (en) | 1999-03-29 |
PT813870E (pt) | 2003-10-31 |
AU2495697A (en) | 1998-01-08 |
US5837724A (en) | 1998-11-17 |
DE69722999D1 (de) | 2003-07-31 |
DK0813870T3 (da) | 2003-08-18 |
CA2208111A1 (en) | 1997-12-18 |
ATE243514T1 (de) | 2003-07-15 |
HU9701060D0 (en) | 1997-08-28 |
EP0813870B1 (en) | 2003-06-25 |
EP0813870A1 (en) | 1997-12-29 |
JPH1059848A (ja) | 1998-03-03 |
HUP9701060A2 (hu) | 1998-12-28 |
GB9612710D0 (en) | 1996-08-21 |
CA2208111C (en) | 2002-10-15 |
KR980000445A (ko) | 1998-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0711902A3 (en) | Fracturing treatment with nitrogen and carbon dioxide in combination | |
GB9714544D0 (en) | Treated titanium dioxide | |
HK1046274A1 (en) | Spiro Ä1-azabicycloÄ2.2.2.Üoctane-3,2'(3'h)-furoÄ2,3-bÜpyridine for use in the treatment of psychotic and intellectual impairment disorders. | |
PT936908E (pt) | Derivados anticonvulsivos uteis no tratamento de esclerose lateral amiotrofica (ela) | |
HK1022270A1 (en) | Use of anti-microtubule agents for treating or preventing multiple-sclerosis | |
BG102999A (en) | New 2,3-diasubstituted-4-(3h)-quinazolinons | |
ZA9811507B (en) | Combination effective for the treatment of impotence. | |
PH31324A (en) | Method of inhibiting imperfect tissue repair. | |
EP0672699A3 (en) | Copolymers of 1,4-dioxepan-2-one and 1,5,8,12-tetraoxacyclotetracan-7-14-diode. | |
IL128379A0 (en) | Treatment of the common cold or allergic rhinitis | |
AU7227394A (en) | Method for surface treatment, means for carrying out the method and the use thereof | |
ZA979731B (en) | Treatment of asthma. | |
ZA97986B (en) | Treatment of liquors. | |
ZA975311B (en) | Method of enhancing cognition | |
AU1556497A (en) | Agents for the treatment and prevention of aids | |
CA2347863A1 (en) | Treatment of disorders of the outer retina | |
GR950100091A (en) | Method for the treatment of plants. | |
ZA973843B (en) | Treatment of asthma with TNFR-lg. | |
EP0612506A3 (en) | Scalpel to make controlled depth and width incisions. | |
EP0888780A4 (en) | COMPOSITION FOR TREATING CONTACT LENSES AND METHOD FOR USE THEREOF | |
UA29461C2 (uk) | Засіб для лікування амілоїдозу, спосіб лікування амілоїдозу | |
ZA977867B (en) | Method of treatment. | |
ZA975637B (en) | Method for the treatment of emesis. | |
HUP0102995A3 (en) | Agents and method for the protective treatment of wood | |
AU4402497A (en) | Methods and means for the treatment of malignancies |